Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Use of Psychoactive Substances in the Context of the Covid-19 Pandemic in Brazil

View ORCID ProfileCésar Augusto Trinta Weber, View ORCID ProfileIngridi Teixeira Monteiro, View ORCID ProfileJulia Medeiros Gehrke, View ORCID ProfileWagner Silva de Souza
doi: https://doi.org/10.1101/2020.09.25.20194431
César Augusto Trinta Weber
1Medical Psychiatrist and Post-doctorate/Department of Neuroscience and Behavioral Sciences at Ribeirão Preto Medical School, USP. Scientific Director, Supervisor and advisor of the Psychiatry Training Program at the Jose de Barros Falcão Study Center, Porto Alegre, RS, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for César Augusto Trinta Weber
  • For correspondence: trintaweber@hotmail.com
Ingridi Teixeira Monteiro
2Psychiatry Training Program, Jose de Barros Falcão Study Center, Porto Alegre, RS, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ingridi Teixeira Monteiro
Julia Medeiros Gehrke
2Psychiatry Training Program, Jose de Barros Falcão Study Center, Porto Alegre, RS, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Medeiros Gehrke
Wagner Silva de Souza
2Psychiatry Training Program, Jose de Barros Falcão Study Center, Porto Alegre, RS, Brazil.
3Master in Psychanalysis/John F Kennedy University Argentina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wagner Silva de Souza
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The protocols for mitigating the transmission of Covid-19 seem to be a trigger for the use of psychoactive substances, as an individual’s adaptive response to support this new way of being in the world. Objective: To investigate the use of psychoactive substances in the context of the Covid-19 pandemic in Brazil. Method: A cross-sectional and prospective observational study, undertaken in a virtual environment. An online survey was developed and employed through Google Forms to collect data. The survey was made available to participants on social networks, Facebook@, Whatsapp@, and Instagram@, linked to the research group, during the period 06/15/2020 to 07/15/2020. 1,145 individuals participated in the research. Results: The average age of the participants was 37 years old. They were mostly female, white, Brazilians, with a higher education level, with occupations in the health field, and had religion. They either maintained their family income or suffered a small income decrease. Moreover, they informed that they were caring for social isolation. The most used substances before and after the beginning of the Covid-19 pandemic were alcohol, tobacco, marijuana, although the use of these substances decreased (P< 0.001). Approximately 32% of the participants started using psychoactive substances in this period. Among them, most individuals started by their own initiative. Conclusions: For a better understanding of the pattern use of psychoactive substances during the Covid-19 pandemic and the adverse effects on human behavior and mental disorders, careful longitudinal studies must be developed, due to the great interest in the knowledge of adaptive responses when people’s lives are at risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received for this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The present study is in agreement with the recommendations of Resolution 466/2012, which provides ethical aspects in research with human beings in all phases. The research is registered at Plataforma Brasil/CONEP as CAAE 33505120.0.0000.5332. The research was approved according to the substantiated opinion number 4.086.949, by the Research Ethics Committee of Sao Pedro Psychiatric Hospital, Porto Alegre, RS.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Use of Psychoactive Substances in the Context of the Covid-19 Pandemic in Brazil
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Use of Psychoactive Substances in the Context of the Covid-19 Pandemic in Brazil
César Augusto Trinta Weber, Ingridi Teixeira Monteiro, Julia Medeiros Gehrke, Wagner Silva de Souza
medRxiv 2020.09.25.20194431; doi: https://doi.org/10.1101/2020.09.25.20194431
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The Use of Psychoactive Substances in the Context of the Covid-19 Pandemic in Brazil
César Augusto Trinta Weber, Ingridi Teixeira Monteiro, Julia Medeiros Gehrke, Wagner Silva de Souza
medRxiv 2020.09.25.20194431; doi: https://doi.org/10.1101/2020.09.25.20194431

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (454)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5288)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (701)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5922)
  • Intensive Care and Critical Care Medicine (366)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (133)
  • Obstetrics and Gynecology (145)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (137)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2033)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)